Seromucinous Hamartoma Presenting as an Obstructive Endobronchial Mass
Journal Title: International Journal of Respiratory and Pulmonary Medicine - Year 2017, Vol 4, Issue 1
Abstract
Seromucinous hamartoma is an extremely rare entity that has been described in the sinonasal cavity and nasopharynx. We here present a case of seromucinous hamartoma manifesting as an obstructive endobronchial mass in a 65-year-old male and active smoker, who presented with dyspnea upon prolonged exertion and atelectasis.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP352733
- DOI 10.23937/2378-3516/1410066
- Views 104
- Downloads 0
Pleural Lipoma
A 31-year-old male presented with complaints of a mild non-productive cough for 2 months. He had no history of smoking, fever, chills, rigors, weight loss, dyspnea, chest pain and hemoptysis. There was no history of expo...
Seromucinous Hamartoma Presenting as an Obstructive Endobronchial Mass
Seromucinous hamartoma is an extremely rare entity that has been described in the sinonasal cavity and nasopharynx. We here present a case of seromucinous hamartoma manifesting as an obstructive endobronchial mass in a 6...
Impact of Adopting 2014 Guidance for Palivizumab Prophylaxis for Children Previously Considered at High Risk for Severe Respiratory Syncytial Virus Disease
Objectives This is a report of pediatric patients hospitalized with Respiratory Syncytial Virus Infection (RSV) during the season prior to, and 2 seasons following the 2014 palivizumab prophylaxis guidance release. The p...
Antiplatelet Exposure and Bleeding Events in Patients Undergoing EBUS-TBNA
Background Periprocedural management of aspirin and clopidogrel, antiplatelet agents, for Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA) remains unclear. Discontinuation of antiplatelet therap...
A Single Center Review of Pleural Fluid Samples
Introduction Large scale epidemiological data of pleural fluid characteristics are lacking. We are an established pleural center with high rates of pleural malignancy in the North East of England. We aim to follow the Br...